China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.82
(0.91%)
USD 1.82
(0.91%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 43.21 Million USD | 2.53% |
| 2023 | 42.15 Million USD | -13.39% |
| 2022 | 48.67 Million USD | 4.04% |
| 2021 | 46.78 Million USD | -14.08% |
| 2020 | 54.45 Million USD | 109.81% |
| 2019 | 25.95 Million USD | 35.3% |
| 2018 | 19.18 Million USD | 51.13% |
| 2017 | 12.69 Million USD | -28.0% |
| 2016 | 17.62 Million USD | 11.66% |
| 2015 | 15.78 Million USD | 90.72% |
| 2014 | 8.27 Million USD | 15.18% |
| 2013 | 7.18 Million USD | 70.74% |
| 2012 | 4.2 Million USD | 55.62% |
| 2011 | 2.7 Million USD | 15.37% |
| 2010 | 2.34 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 43.21 Million USD | 11.94% |
| 2024 Q1 | 31.96 Million USD | -24.17% |
| 2024 Q3 | 38.61 Million USD | 4.32% |
| 2024 FY | 43.21 Million USD | 2.53% |
| 2024 Q2 | 37.01 Million USD | 15.78% |
| 2023 Q3 | 37.02 Million USD | -11.13% |
| 2023 FY | 42.15 Million USD | -13.39% |
| 2023 Q1 | 36.59 Million USD | -24.81% |
| 2023 Q2 | 41.65 Million USD | 13.83% |
| 2023 Q4 | 42.15 Million USD | 13.86% |
| 2022 Q1 | 50.59 Million USD | 8.15% |
| 2022 FY | 48.67 Million USD | 4.04% |
| 2022 Q4 | 48.67 Million USD | 7.34% |
| 2022 Q3 | 45.34 Million USD | -13.07% |
| 2022 Q2 | 52.15 Million USD | 3.09% |
| 2021 Q1 | 52.07 Million USD | -4.37% |
| 2021 Q3 | 52.74 Million USD | 8.63% |
| 2021 FY | 46.78 Million USD | -14.08% |
| 2021 Q2 | 48.55 Million USD | -6.76% |
| 2021 Q4 | 46.78 Million USD | -11.31% |
| 2020 Q2 | 36.09 Million USD | -3.05% |
| 2020 FY | 54.45 Million USD | 109.81% |
| 2020 Q3 | 41.91 Million USD | 16.11% |
| 2020 Q4 | 54.45 Million USD | 29.91% |
| 2020 Q1 | 37.23 Million USD | 43.47% |
| 2019 Q3 | 25.27 Million USD | 62.94% |
| 2019 Q1 | 13.55 Million USD | -29.3% |
| 2019 FY | 25.95 Million USD | 35.3% |
| 2019 Q4 | 25.95 Million USD | 2.69% |
| 2019 Q2 | 15.5 Million USD | 14.38% |
| 2018 Q2 | 12.87 Million USD | -2.35% |
| 2018 FY | 19.18 Million USD | 51.13% |
| 2018 Q4 | 19.18 Million USD | -1.05% |
| 2018 Q3 | 19.38 Million USD | 50.59% |
| 2018 Q1 | 13.18 Million USD | 3.86% |
| 2017 Q2 | 11.7 Million USD | 0.86% |
| 2017 Q1 | 11.6 Million USD | -34.17% |
| 2017 FY | 12.69 Million USD | -28.0% |
| 2017 Q4 | 12.69 Million USD | 3.65% |
| 2017 Q3 | 12.24 Million USD | 4.62% |
| 2016 Q1 | 19.53 Million USD | 23.73% |
| 2016 FY | 17.62 Million USD | 11.66% |
| 2016 Q4 | 17.62 Million USD | 3.27% |
| 2016 Q3 | 17.06 Million USD | 0.72% |
| 2016 Q2 | 16.94 Million USD | -13.23% |
| 2015 Q3 | 15.18 Million USD | 32.38% |
| 2015 Q4 | 15.78 Million USD | 3.94% |
| 2015 FY | 15.78 Million USD | 90.72% |
| 2015 Q1 | 9.29 Million USD | 12.36% |
| 2015 Q2 | 11.47 Million USD | 23.36% |
| 2014 Q3 | 8.2 Million USD | 22.33% |
| 2014 FY | 8.27 Million USD | 15.18% |
| 2014 Q1 | 7.29 Million USD | 1.56% |
| 2014 Q4 | 8.27 Million USD | 0.83% |
| 2014 Q2 | 6.71 Million USD | -8.06% |
| 2013 Q4 | 7.18 Million USD | 6.64% |
| 2013 FY | 7.18 Million USD | 70.74% |
| 2013 Q1 | 5.61 Million USD | 33.33% |
| 2013 Q2 | 6.54 Million USD | 16.57% |
| 2013 Q3 | 6.73 Million USD | 3.02% |
| 2012 Q3 | 4.83 Million USD | 93.88% |
| 2012 Q1 | 2.27 Million USD | -15.94% |
| 2012 Q4 | 4.2 Million USD | -12.98% |
| 2012 FY | 4.2 Million USD | 55.62% |
| 2012 Q2 | 2.49 Million USD | 9.73% |
| 2011 FY | 2.7 Million USD | 15.37% |
| 2011 Q1 | 3.06 Million USD | 30.52% |
| 2011 Q4 | 2.7 Million USD | 0.55% |
| 2011 Q3 | 2.68 Million USD | 39.86% |
| 2011 Q2 | 1.92 Million USD | -37.15% |
| 2010 Q2 | 1.77 Million USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 FY | 2.34 Million USD | 0.0% |
| 2010 Q4 | 2.34 Million USD | 7.16% |
| 2010 Q3 | 2.18 Million USD | 23.26% |
| 2009 Q4 | 7800.00 USD | 50.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | 5200.00 USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 1.32 Million USD | -3174.068% |
| BIMI International Medical Inc. | 5.45 Million USD | -692.25% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | 77.313% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 76.405% |
| Leafly Holdings, Inc. | 29.08 Million USD | -48.599% |
| Leafly Holdings, Inc. | 29.08 Million USD | -48.599% |
| LifeMD, Inc. | 18.93 Million USD | -128.286% |
| LifeMD, Inc. | 18.93 Million USD | -128.286% |
| TRxADE HEALTH, Inc. | 7.1 Million USD | -508.397% |
| PetMed Express, Inc. | 1.45 Million USD | -2872.487% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 99.548% |